title: A radioreceptor assay for quantitating plasma factor VIII/von Willebrand's protein.
abstract: A sensitive and precise radioreceptor assay for determining plasma levels of human factor VIII/von Willebrand's factor (FVIII/vWF) has been developed by taking advantage of the FVIII/vWF receptor sites on human platelets. Paraformaldehyde-fixed platelets, which were processed and then stored, retained FVIII/vWF binding activity and therefore could be used as a convenient source of receptors. The human plasma samples to be tested were initially filtered on 4% agarose columns to concentrate the FVIII/vWF protein in the void volume and to remove the factor(s) that interferes with the assay. The percent recovery of FVIII/vWF in the pooled eluent was measured by the recovery of added trace 125I-FVIII/vWF. The coefficients of intra- and interassay variation were 6% and 10%, respectively. The plasma FVIII/vWF concentrations determined by the assay for pooled normal plasma, hemophilia A plasma, and plasmas from two patients with von Willebrand's disease were 16.3 +/- 0.5, 52.6 +/- 1.5, 6.8 +/- 0.8, and 3.2 +/- 0.2 microgram/ml, respectively. The range of plasma FVIII/vWF concentrations varied between 8.3 microgram/ml and 24.9 microgram/ml for 10 normal adults. The plasma FVIII/vWF concentrations determined by the radioreceptor assay correlated well with levels measured by the ristocetin-induced platelet aggregation method, thus demonstrating the functional relevancy of the radioreceptor assay for plasma FVIII/vWF.
mesh_terms: D001779:Blood Coagulation Factors / Q000032:analysis*; D001792:Blood Platelets; D005167:Factor VII / Q000032:analysis*; D006801:Humans; D010974:Platelet Aggregation / Q000187:drug effects; D011869:Radioligand Assay / Q000379:methods*; D012310:Ristocetin; D014841:von Willebrand Factor / Q000032:analysis*
chemical_list: D001779:Blood Coagulation Factors; D014841:von Willebrand Factor; D012310:Ristocetin; D005167:Factor VII